Join to View Full Profile
4488 Forest Park AveSte 160St. Louis, MO 63108
Phone+1 314-362-1408
Fax+1 314-286-1985
Dr. Snider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. B. Joy Snider is a neurologist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital. She received her medical and graduate degrees (PhD in Biochemistry) from University of Texas Southwestern Medical School and has been in practice 28 years. She specializes in dementia & geriatrics and is experienced in Alzheimer disease and behavioral neurology / neuropsychiatry. She leads the Knight ADRC Clinical Trials Unit and serves as the Medical Director for the faculty dementia specialty practice, the Memory Diagnostic Center. She served as the Adult Neurology Residency Program Director from 2009-2022 and now serves as co-principal investigator of the Knight ADRC T32 Training program and of the Knight ADRC Research Educational Component.
Education & Training
University of Texas Southwestern Medical CenterResidency, Neurology, 1990 - 1993
Texas Health Resources (Dallas)Internship, Internal Medicine, 1989 - 1990
University of Texas Southwestern Medical SchoolClass of 1989
Certifications & Licensure
IL State Medical License 2021 - 2026
MO State Medical License 1993 - 2026
OK State Medical License 2020 - 2021
TX State Medical License 1990 - 2000
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesGeriatric Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
Publications & Presentations
PubMed
- 19 citationsAssociation Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic.Abigail Lewis, Aditi Gupta, Inez Oh, Suzanne E Schindler, Nupur Ghoshal
Neurology. 2023-10-03 - 27 citationsAmyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.Nelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, Austin A McCullough, Carsten Hofmann
Annals of Neurology. 2022-11-01 - 4 citationsEffects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease.B. Joy Snider, David M. Holtzman
Neuron. 2021-08-24
Press Mentions
Lecanemab for Alzheimer Disease Safe, Feasible in Real-World PracticeMay 16th, 2025- Drug That Slows Alzheimer's Is Safe and Effective, Real-World Data ShowsMay 16th, 2025
- Lecanemab for Alzheimer Disease Safe, Feasible in Real-World PracticeMay 16th, 2025
- Join now to see all
Grant Support
- Multidisciplinary Training in Alzheimer and Related DementiasWASHINGTON UNIVERSITY2018–2029
- Neuroprotective Effects Of Enhanced Proteasome FunctionNational Institute Of Neurological Disorders And Stroke2004–2006
- Neuroprotective Effect Of Heat Stress In Cortical NeuronNational Institute Of Neurological Disorders And Stroke1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
